Baricitinib
Baricitinib (LY3009104, INCB028050) is a selective JAK1 and JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM in cell-free assays.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
371.42
Molecular Formula
C16H17N7O2S
Notes
Research use only, not for human use.
Receptor
Chk2| JAK1| JAK2| JAK3| Tyk2
CAS Number
1187594-09-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Succinyl-CoA Synthetase Subunit alpha (SCS-alpha, GALPHA, MTDPS9, Succinyl-CoA Ligase [GDP-forming] Subunit alpha Mitochondrial, SUCLA1, SUCLG1)](https://cdn.genprice.uk/genprice/genprice5.png)
MBS644551-01 0.1 mL
Succinyl-CoA Synthetase Subunit alpha (SCS-alpha, GALPHA, MTDPS9, Succinyl-CoA Ligase [GDP-forming] Subunit alpha Mitochondrial, SUCLA1, SUCLG1)
Ask
View Details ![Succinyl-CoA Synthetase Subunit alpha (SCS-alpha, GALPHA, MTDPS9, Succinyl-CoA Ligase [GDP-forming] Subunit alpha Mitochondrial, SUCLA1, SUCLG1)](https://cdn.genprice.uk/genprice/genprice2.png)
MBS644551-02 5x 0.1 mL
Succinyl-CoA Synthetase Subunit alpha (SCS-alpha, GALPHA, MTDPS9, Succinyl-CoA Ligase [GDP-forming] Subunit alpha Mitochondrial, SUCLA1, SUCLG1)
Ask
View Details 